Brinckerhoff Quoted on Patent Trolling in Biopharma
24 July 2013
Genetic Engineering and Biotechnology
Washington, D.C. Partner Courtenay Brinckerhoff was quoted in an article published in Genetic Engineering and Biotechnology News on July 24, 2013 titled “New Gene Patent Suit Sparks Talk of Trolls.” The article discusses a lawsuit issued by Myriad Genetics and whether or not it means patent trolling has come to biopharma. Ms. Brinckerhoff was quoted saying, “Before biotech companies decide to go into the market, they might be more cognizant or concerned about whether they have time to operate, because they’re going to invest a lot of time and money to get there.”
People
Related News
08 November 2024
In the News
Federico Goudie on Brazil as Key Market – 'It just happens that Miami is a smart place to be'
Foley & Lardner LLP partner Federico Goudie shared insight on the growing importance of Brazil to the U.S. legal market in Daily Business Review, identifying Miami as a key place to be for firms working with Brazilian clients and Latin American clients more broadly.
08 November 2024
In the News
Louis Lehot Assesses 2024 Election Result, Prospect of Tech Deal Resurgence
Foley & Lardner LLP partner Louis Lehot appeared across legal and business press to discuss the likelihood of a resurgence across capital markets, venture capital, and tech M&A following the results of the 2024 U.S. presidential election.
07 November 2024
In the News
James McKee on Amendment 3's Failed Passage – 'Florida still has a significant market'
Foley & Lardner LLP partner James McKee's assessment of the future of the cannabis industry in Florida following the failed passage of Amendment 3, a constitutional amendment that would have legalized recreational use of marijuana for adults, appeared across media outlets, including CBS News Miami, NBC 6 South Florida, NPR/WUSF, Orlando Sentinel, South Florida Sun Sentinel, and WMNF 88.5 FM.